Atlas of Genetics and Cytogenetics in Oncology and Haematology


Home   Genes   Leukemias   Solid Tumours   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA

Bone: Chondroblastoma

Identity

Note Chondroblastoma is a benign bone tumour typically affecting the epiphyses of long bones from individuals with an immature skeleton.
Radiology of Chondroblastoma.
FIG. 1,2,3: Typical radiological findings of a lytic eccentric lesion affecting the epyphysis of the humerus (1 RX, 2 NMR and 3 bone scan)

Clinics and Pathology

Epidemiology Chondroblastoma is a rare neoplasm accounting for less than 1% of all bone tumors. Age of occurrence is usually between 10 and 25 years with a male predominance. Older age of presentation for skull lesions is reported.
Clinics Usual symptom at presentation is mild localized pain. Radiologically it occurs more often as an eccentric lytic lesion, with sclerotic borders, involving epiphyses of the long bones.
Pathology The tumour is composed of cellular and matrix rich areas. Cellular areas are made up of so called ³chondroblasts²: round-,or polygonal cells, with an oval to round nucleus and with well defined eosinophilic cytoplasm. Mainly in non-decalcified sections the chondroblasts appear focally delimited by a thin calcification rim, so called ³chicken wire². Matrix rich areas are composed of different types of matrix: chondroid, osteoid, fibrous and rarely mature hyaline cartilage. Mitoses, always typical, are quite frequent, especially in the cellular areas.
Immunohistochemical stainings show reactivity of the neoplastic cells for S-100 protein and Vimentin; although several other antigens are reported to be expressed (i.e. Smooth muscle actin and Cytokeratin). Multinucleated giant cells, especially at the periphery of matrix-rich areas, are almost always found. An associated aneurysmal bone cyst occurs in about 1/3 of the cases.
 
Histological features of chondroblastoma.
Fig.4: The cellular areas are made up of polygonal cells with scattered multinucleated giants cells (Haematoxylin-Eosin stain).
Fig.5: The polygonal cells are positive for S-100 immunostain.
Treatment Simple curettage is the standard treatment.
Evolution Rate of recurrence is between 14-18% mainly occurring within 2 years, and showing a higher occurrence rate in case of temporal bone location. Rare lung metastases in benign chondroblastomas, are documented. However they are not progressive, and therefore simple observation is sufficient, if necessary followed by simple surgical resection.
Prognosis The prognosis is good. Rare and doubtful malignant progression are described, but no universal criteria for this event are currently available, and several authors consider this as cases of a misdiagnosis.

Cytogenetics

Cytogenetics
Morphological
DNA flow cytometry studies show chondroblastoma mainly to be a low proliferative diploid neoplasm, however aneuploid near-diploid populations have been reported.
Karyotypic results of 7 cases are available in the literature. No specific cytogenic abnormalities neither specific type of aberrations are reported sofar. However some chromosomes seem to be more often involved: 3 cases for chromosome 5, 2 for chromosome 8, 2 for chromosome 11 and 2 for chromosome 17.

Bibliography

Cytophotometric studies of the nuclear DNA content in cartilaginous tumors.
Cuvelier C, Roels HJ.
Cancer 1979; 44: 1363-1374.
PMID 80044542
 
Chondroblastoma: a clinical and radiological study of 104 cases.
Bloem JL, Mulder JD.
Skeletal Radiol 1985; 14(1): 1-9.
PMID 4023729
 
S-100 protein immunostaining in the differential diagnosis of chondroblastoma.
Monda L, Wick MR.
Hum Pathol 1985; 16(3): 287-293.
PMID 2579018
 
Chondroblastoma. A review of seventy cases.
Springfield DS, Capanna R, Gherlinzoni F, Picci P, Campanacci M.
J Bone Joint Surg Am 1985; 67(5): 748-755.
PMID 3997927
 
Histology and biology of metastatic chondroblastoma. Report of a case with a review of the literature.
Kunze E, Graewe T, Peitsch E.
Pathol Res Pract 1987; 182(1): 113-123.
PMID 3588400
 
Radiologic case study. Chondroblastoma.
Monticciolo DL, Brown NL.
Orthopedics 1987; 10(8): 1197, 1199-1201.
PMID 3628108
 
Chondroblastoma of the temporal bone.
Blaauw G, Prick JJ, Versteege C.
Neurosurgery 1988; 22: 1102-1107.
PMID 3047595
 
Chondroblastoma: an immunohistochemical study.
Brecher ME, Simon MA.
Hum Pathol 1988; 19(9): 1043-1047.
PMID 3417289
 
Immunohistochemical distribution of S-100 protein in tumors and tumor-like lesions of bone and cartilage.
Okajima K, Honda I, Kitagawa T.
Cancer 1988; 61: 792-799.
PMID 88109271
 
Chondroblastoma of bone.
Kurt AM, Turcotte RE, McLeod RA,  Unni KK, Sim FH.
Orthopedics 1990; 13(7): 787-790.
PMID 2197612
 
Cytokeratin expression in chondroblastoma.
Semmelink HJF, Pruszczynski M, Wiersma-van Tilburg AJM., Smedts F, Ramaekers FCS.
Histopathology 1990; 16: 257-263.
PMID 90236432
 
Epiphyseal chondroblastoma of bone. Long-term effects on skeletal growth and articular function in 15 cases treated surgically.
Caterini R, Manili M, Spinelli M, Santori FS, Ippolito E.
Arch Orthop Trauma Surg 1992; 111(6): 327-332.
PMID 1449941
 
Chondroblastoma of bone. A clinical, radiological, light and immunohistochemical study.
Edel G, Ueda Y, Nakanishi J, Brinker KH, Roessner A, Blasius S, Vestring T, Muller-Miny H, Erlemann R, Wuisman P.
Virchows Arch A Pathol Anat Histopathol 1992; 421(4): 355-366.
PMID 1384228
 
Human benign chondroblastoma with a pseudodiploid stemline characterized by a complex and balanced translocation.
Mark J, Wedell B, Dahlenfors R, Grepp C, Burian P.
Cancer Genet Cytogenet 1992; 58(1): 14-17.
PMID 1728944
 
Chondroblastoma of the temporal bone. Case report and literature review.
Varvares MA, Cheney ML, Goodman ML, Ceisler E, Montgomery WW.
Ann Otol Rhinol Laryngol 1992; 101(9): 763-769.
PMID 1514755
 
Biologic and clinical significance of cytogenetic and molecular cytogenetic abnormalities in benign and malignant cartilaginous lesions.
Bridge JA, Bhatia PS, Anderson JR, Neff JR.
Cancer Genet Cytogenet 1993; 69: 79-90.
PMID 94006162
 
Chondroblastoma.
Pflueger P,  Heinrich SD, Craver R.
Orthopedics 1993; 16(3): 339-342.
PMID 8464774
 
Chondroblastoma.
Turcotte RE, Kurt AM, Sim FH, Unni KK, McLeod RA.
Hum Pathol 1993; 24(9): 944-949.
PMID 8253461
 
Ultrastructural cytochemical demonstration of proteoglycans and calcium in the extracellular matrix of chondroblastomas.
Mii Y, Miyauchi Y, Morishita T, Miura S, Honoki K, Aoki M, Tamai S.
Hum Pathol 1994; 25(12): 1290-1294.
PMID 8001922
 
Chondroblastoma: classic and confusing appearance at MR imaging.
Weatherall PT, Maale GE, Mendelsohn DB, Sherry CS, Erdman WE, Pascoe HR.
Radiology 1994; 190(2): 467-474.
PMID 8284401
 
Benign cartilage tumors.
Scarborough MT, Moreau G.
Orthop Clin North Am 1996; 27(3): 583-589.
PMID 8649739
 
Benign and malignant cartilage tumors of bone and joint: their anatomic and theoretical basis with an emphasis on radiology, pathology and clinical biology. I. The intramedullary cartilage tumors.
Brien EW, Mirra JM, Kerr R.
Skeletal Radiol 1997; 26(6): 325-353.
PMID 9229417
 
Ring chromosome 4 as the sole cytogenetic anomaly in a chondroblastoma: a case report and review of the literature.
van Zelderen-Bhola SL, Bovee JV, Wessels HW, Mollevanger P, Nijhuis JV, van Eendenburg JD, Taminiau AH, Hogendoorn PC.
Cancer Genet Cytogenet 1998; 105(2): 109-112.
PMID 9723025
 
Cartilage-forming tumours of bone and soft tissue and their differential diagnosis.
Bovee JV, Hogendoorn PC.
Current Diagnostic Pathology 2002; 7[4]: 223-234.
 
Chondroblastoma. In: Fletcher CDM, Unni KK, Mertens F, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone.
Kilpatrick SE, Parisien M, Bridge JA.
Lyon: IARC Press 2002; 241-242
 
 Correlation between clinicopathological features and karyotype in 100 cartilaginous and chordoid tumours. A report from the Chromosomes and Morphology (CHAMP) Collaborative Study Group.
Tallini G, Dorfman H, Brys P, Dal Cin P, De Wever I, Fletcher CD, Jonson K, Mandahl N, Mertens F, Mitelman F, Rosai J, Rydholm A, Samson I, Sciot R, Van Den Berghe H, Vanni R, Willen H.
Journal of Pathology 2002; 196[2]: 194-203.
PMID 21653061
 
Cytogenetic findings in benign cartilaginous neoplasms.
Buddingh EP, Naumann S, Nelson M, Neffa JR, Birch N, Bridge JA.
Cancer Genet Cytogenet 2003; 141(2): 164-168.
PMID 12606137
 
Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: osteosarcoma and related tumors.
Sandberg AA, Bridge JA.
Cancer Genet Cytogenet 2003; 145(1): 1-30.
PMID 12885459
 
REVIEW articlesautomatic search in PubMed
Last year publicationsautomatic search in PubMed

Contributor(s)

Written07-2003Salvatore Romeo, Pancras CW Hogendoorn
Leiden University Medical Center, P.O. box 9600, L1-Q, 2300 RC Leiden, The Netherlands

Citation

This paper should be referenced as such :
Romeo S, Hogendoorn PCW . Bone: Chondroblastoma. Atlas Genet Cytogenet Oncol Haematol. July 2003 .
URL : http://AtlasGeneticsOncology.org/Tumors/ChondroblastomaID5148.html

© Atlas of Genetics and Cytogenetics in Oncology and Haematology
indexed on : Thu Apr 17 14:14:27 2008


Home   Genes   Leukemias   Solid Tumours   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

For comments and suggestions or contributions, please contact us

j.l.huret@chu-poitiers.fr.